• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灵长类动物发育过程中对帕金森病毒素的易感性会发生变化。

Susceptibility to a parkinsonian toxin varies during primate development.

机构信息

Neuropsychopharmacology Research Laboratory, Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06511, USA.

出版信息

Exp Neurol. 2012 May;235(1):273-81. doi: 10.1016/j.expneurol.2012.02.005. Epub 2012 Feb 14.

DOI:10.1016/j.expneurol.2012.02.005
PMID:22366325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3334464/
Abstract

Symptoms of Parkinson's disease typically emerge later in life when loss of nigrostriatal dopamine neuron function exceeds the threshold of compensatory mechanisms in the basal ganglia. Although nigrostriatal dopamine neurons are lost during aging, in Parkinson's disease other detrimental factors must play a role to produce greater than normal loss of these neurons. Early development has been hypothesized to be a potentially vulnerable period when environmental or genetic abnormalities may compromise central dopamine neurons. This study uses a specific parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), to probe the relative vulnerability of nigrostriatal dopamine neurons at different stages of primate development. Measures of dopamine, homovanillic acid, 1-methyl-pyridinium concentrations and tyrosine hydroxylase immunoreactive neurons indicated that at mid-gestation dopamine neurons are relatively vulnerable to MPTP, whereas later in development or in the young primate these neurons are resistant to the neurotoxin. These studies highlight a potentially greater risk to the fetus of exposure during mid-gestation to environmental agents that cause oxidative stress. In addition, the data suggest that uncoupling protein-2 may be a target for retarding the progressive loss of nigrostriatal dopamine neurons that occurs in Parkinson's disease and aging.

摘要

帕金森病的症状通常在生命后期出现,此时黑质纹状体多巴胺神经元功能丧失超过基底神经节代偿机制的阈值。尽管在衰老过程中黑质纹状体多巴胺神经元会丢失,但在帕金森病中,其他有害因素也必须发挥作用,才能导致这些神经元的非正常丢失。早期发育被假设为一个潜在的脆弱时期,在此期间,环境或遗传异常可能会损害中枢多巴胺神经元。本研究使用特定的帕金森病神经毒素 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)来探究不同灵长类动物发育阶段黑质纹状体多巴胺神经元的相对易损性。多巴胺、高香草酸、1-甲基吡啶离子浓度和酪氨酸羟化酶免疫反应性神经元的测量表明,在妊娠中期,多巴胺神经元对 MPTP 相对敏感,而在发育后期或年幼的灵长类动物中,这些神经元对神经毒素具有抗性。这些研究强调了在妊娠中期暴露于引起氧化应激的环境因素对胎儿的潜在更大风险。此外,数据表明解偶联蛋白-2可能是延缓帕金森病和衰老过程中黑质纹状体多巴胺神经元进行性丧失的靶点。

相似文献

1
Susceptibility to a parkinsonian toxin varies during primate development.灵长类动物发育过程中对帕金森病毒素的易感性会发生变化。
Exp Neurol. 2012 May;235(1):273-81. doi: 10.1016/j.expneurol.2012.02.005. Epub 2012 Feb 14.
2
Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.促觉醒药物莫达非尼对黑小鼠中MPTP诱导的黑质纹状体多巴胺神经元变性的保护作用的证据:免疫细胞化学和生化分析。
Exp Brain Res. 1992;88(1):117-30. doi: 10.1007/BF02259133.
3
A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.一种新型抗帕金森病药物,佐尼沙胺,可减轻 MPTP 诱导的小鼠神经毒性。
J Mol Neurosci. 2009 Sep;39(1-2):211-9. doi: 10.1007/s12031-009-9181-z. Epub 2009 Feb 7.
4
EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.EGb761对1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的小鼠帕金森病黑质纹状体多巴胺能神经毒性具有保护作用:氧化应激的作用
Eur J Neurosci. 2008 Jul;28(1):41-50. doi: 10.1111/j.1460-9568.2008.06314.x.
5
Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's disease.
J Alzheimers Dis. 2008 Sep;15(1):97-107. doi: 10.3233/jad-2008-15108.
6
Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.MPTP处理的C57BL/6小鼠中黑质纹状体多巴胺能神经元的自发再生
Biochem Biophys Res Commun. 1998 Jul 30;248(3):660-3. doi: 10.1006/bbrc.1998.8986.
7
Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.C57/bl和CD-1小鼠黑质神经元数量及对1-甲基-4-苯基-1,2,3,6-四氢吡啶敏感性的差异。
Exp Neurol. 1994 Apr;126(2):195-204. doi: 10.1006/exnr.1994.1058.
8
Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.熊果酸可减轻黑质纹状体组织中的氧化应激,并改善MPTP诱导的帕金森病小鼠模型的神经行为活动。
J Chem Neuroanat. 2016 Jan;71:41-9. doi: 10.1016/j.jchemneu.2015.12.002. Epub 2015 Dec 12.
9
Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.G蛋白偶联受体6缺陷小鼠对MPTP神经毒性的易感性增加。
Neuroscience. 2016 Nov 19;337:218-223. doi: 10.1016/j.neuroscience.2016.09.021. Epub 2016 Sep 17.
10
Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion.端粒酶缺陷小鼠黑质中大量端粒缩短并未增加对MPTP诱导的多巴胺耗竭的易感性。
Neuroreport. 2014 Mar 26;25(5):335-9. doi: 10.1097/WNR.0000000000000099.

引用本文的文献

1
Pioglitazone transiently stimulates paraoxonase-2 expression in male nonhuman primate brain: Implications for sex-specific therapeutics in neurodegenerative disorders.吡格列酮短暂刺激雄性非人灵长类动物大脑中的对氧磷酶 2 表达:对神经退行性疾病中性别特异性治疗的启示。
Neurochem Int. 2022 Jan;152:105222. doi: 10.1016/j.neuint.2021.105222. Epub 2021 Nov 9.
2
PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders.过氧化物酶体增殖物激活受体 γ/辅激活因子 1α 信号通路作为神经退行性疾病中线粒体生物发生的潜在治疗靶点。
Pharmacol Ther. 2021 Mar;219:107705. doi: 10.1016/j.pharmthera.2020.107705. Epub 2020 Oct 9.
3
Parkinson's disease treatment: past, present, and future.帕金森病的治疗:过去、现在和未来。
J Neural Transm (Vienna). 2020 May;127(5):785-791. doi: 10.1007/s00702-020-02167-1. Epub 2020 Mar 14.
4
Pioglitazone activates paraoxonase-2 in the brain: A novel neuroprotective mechanism.吡格列酮激活大脑中的对氧磷酶 2:一种新的神经保护机制。
Exp Neurol. 2020 May;327:113234. doi: 10.1016/j.expneurol.2020.113234. Epub 2020 Feb 7.
5
MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes.MPTP 诱导中年食蟹猴出现系统性帕金森病:临床演变和结局。
Neurosci Bull. 2017 Feb;33(1):17-27. doi: 10.1007/s12264-016-0069-y. Epub 2016 Oct 3.
6
Developmental expression of paraoxonase 2.对氧磷酶2的发育表达
Chem Biol Interact. 2016 Nov 25;259(Pt B):168-174. doi: 10.1016/j.cbi.2016.04.001. Epub 2016 Apr 7.

本文引用的文献

1
Barriers in the developing brain and Neurotoxicology.发育中的大脑与神经毒理学障碍。
Neurotoxicology. 2012 Jun;33(3):586-604. doi: 10.1016/j.neuro.2011.12.009. Epub 2011 Dec 19.
2
Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.苯丙胺对灵长类多巴胺神经元的影响取决于年龄:对帕金森病发病机制的影响。
Neuroscience. 2011 Aug 25;189:277-85. doi: 10.1016/j.neuroscience.2011.05.046. Epub 2011 Jun 1.
3
Etiology and pathogenesis of Parkinson's disease.帕金森病的病因和发病机制。
Mov Disord. 2011 May;26(6):1049-55. doi: 10.1002/mds.23732.
4
A tale on animal models of Parkinson's disease.帕金森病动物模型的故事。
Mov Disord. 2011 May;26(6):993-1002. doi: 10.1002/mds.23696.
5
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.衰老作为帕金森病的一个主要风险因素:来自非人类灵长类动物研究的证据。
Nat Rev Neurosci. 2011 Jun;12(6):359-66. doi: 10.1038/nrn3039. Epub 2011 May 18.
6
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.帕金森病动物模型:新型治疗方法的来源和疾病病因的线索。
Br J Pharmacol. 2011 Oct;164(4):1357-91. doi: 10.1111/j.1476-5381.2011.01426.x.
7
Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.基因-环境相互作用:揭开帕金森病之谜的关键。
Prog Neurobiol. 2011 Jun;94(1):1-19. doi: 10.1016/j.pneurobio.2011.03.005. Epub 2011 Mar 23.
8
The environment and susceptibility to schizophrenia.环境与精神分裂症易感性。
Prog Neurobiol. 2011 Jan;93(1):23-58. doi: 10.1016/j.pneurobio.2010.09.003. Epub 2010 Oct 16.
9
Gene-environment interactions in Parkinson's disease: the importance of animal modeling.帕金森病中的基因-环境相互作用:动物模型的重要性。
Clin Pharmacol Ther. 2010 Oct;88(4):467-74. doi: 10.1038/clpt.2010.138. Epub 2010 Sep 1.
10
Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.伴有苯丙胺类药物使用障碍的住院患者中帕金森病的发病率。
Mov Disord. 2010 Oct 30;25(14):2333-9. doi: 10.1002/mds.23263.